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Background: Treatment of breast ﬁbroadenoma remains a subject of clinical discussion. Rec-
ommended methods include clinical observation or surgical excision of the lesion. The
procedure involves hospitalisation and anaesthesia, leaving a scar on the breast.
Aim: The aim of this study was to present the Centre’s experience in removing lesions radi-
ologically suspicious of ﬁbroadenoma by means of an ultrasound-guided vacuum-assisted
core-needle biopsy as an alternative to a classical surgery.
Materials and methods: Between March 2007 and April 2010, 196 ultrasound-guided vacuum-
assisted biopsies were performed in the Mammotome Biopsy Laboratory of the 1st Surgical
Oncology and General Surgery Department at the Greater Poland Cancer Centre in Poznan´.
The procedure was delivered to female patients aged 17–91 years (mean 40.8, median 39).
Qualiﬁed for removal were ultrasound identiﬁed lesions described as ﬁbroadenomas.
Results: The average size of excised lesions according to pre-biopsy ultrasound image was
13.53±8.92mm (median 11mm, range 4–60mm). In 184 cases (93.9%), benign lesions were
found in the ﬁnal histopathologic examination. Pre-cancer lesions were found in 10 cases,
and invasive lesions in two cases. Overall, after follow-up ultrasound examination, fourpatientswerequaliﬁed for subsequent surgical resectionof lesions that hadbeen left behind.
Conclusion: Vacuum core-needle biopsy is an effective tool enabling removal of breast
ﬁbroadenomas. It combines features of a lesion resection and histopathologic material
collection providing an access with minimum invasiveness.
land
The lesion occurs rarely in the post-menopausal period; how-© 2010 Greater Po
1. IntroductionFibroadenoma is a benign tumour, in most cases distinctly
separated from the surrounding tissue, originating from the
epithelium and stroma of the terminal ductolobular unit. It
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is most common in young women under 25 years of age.ever, with hormone-replacement therapies widely used, the
prevalence of ﬁbroadenoma has increased in that age group,
too.1 The most frequent clinical manifestation is a palpable
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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eFig. 1 – Ultrasound image of ﬁbroadenoma sized
umour detected during self-examination of the breast or con-
rol medical examination. In most cases, tumours are found
o be smooth-surfaced, painless, and mobile in relation to
heir surrounding tissue, sized 1–3 cm. Larger or multifocal
broadenoma lesions occur in less than 20% of cases. Accord-
ng to Smalwood et al., 15% of lesions regress, while 19% grow
n size.2 In most cases, having reached the size of 2–3 cm, they
emain static for months or even years. Sometimes, ﬁbroade-
omas are found to co-exist with phyllodes tumours. These
esions may be difﬁcult to distinguish in clinical and ultra-
ound examination. Large size, fast growth and ultrasound
isible liquid-ﬁlled areas suggesting phyllodes tumour may
rove to be useful differentiating characteristics. Transforma-
ion into a malignant neoplasm is extremely rare. As Ozello
nd Gump report, it applies to 0.3% of cases in women under
0 years of age.3 Lobular cancers are then observedmore likely
han ductal lesions.
A triple test comprising clinical examination, ultrasound
nd biopsy remains the basic method for diagnosing ﬁbroade-
omas. Fine-needle or core-needle biopsy may be proposed in
rder to collect material for histopathologic examination.
Treatment of breast ﬁbroadenoma remains a subject of
linical discussion. For non-palpable lesions, clinical obser-
ation, including necessary ultrasound, and histopathologic
iagnosis are recommended. For palpable lesions, some
uthors recommend surgical excision, given patients’ anxiety
nd their frequent reluctance to cooperate in the monitoring
f such lesions. Others propose observation until the age of
5 and surgical procedure, should the lesion fail to regress.
he surgery involves hospitalisation and anaesthesia, leaving
scar on the breast. In recent years, a new option has emergedor minimal invasive treatment of benign breast lesions –
ltrasound-guided vacuum-assisted biopsy.
The aim of this study was to present the Centre’s
xperience in removing lesions radiologically suspicious ofmm×18.5mm prior to vacuum-assisted biopsy.
ﬁbroadenomabymeansof anultrasoundguidedvacuumcore-
needle biopsy.
2. Materials and methods
Between March 2007 and April 2010, 196 ultrasound-guided
vacuum biopsies were performed in the Mammotome Labo-
ratory of the 1st Oncologic and General Surgery Department
at the Greater Poland Cancer Centre in Poznan´. The procedure
was delivered to female patients aged 17–91 years (mean 40.8,
median 39). Qualiﬁed for removalwere ultrasounddemonstra-
ble lesions described as consistent with ﬁbroadenoma (Fig. 1).
The biopsies were initially performed with Mammotom man-
ufactured by Ethicon Endo-Surgery Inc., USA, then with the
equipment of Encor Breast Biopsy System Sono RX Inc. USA,
under the guidance Siemens Sonoline G20 ultrasound system,
Siemens Medical Solutions Inc. USA. As a rule, procedures
were performed in an outpatient setting, in 13 cases they
were performed in patients hospitalised at the 1st Oncologic
and General Surgery Department, preliminarily qualiﬁed for
surgical excision of the lesion. The procedures, preceded by
sterile draping of the operative ﬁeld, were performed with
single-use needles 8, 11 G (Mammotom) or 7, 10 G (EnCor). All
patients were informed of the method to be used, the ben-
eﬁts and possible complications arising from it. They were
also advised that a surgical resection of the lesion would be
necessary if pre-cancer, pre-invasive or invasive lesions were
to be found. Biopsy sites were locally anaesthetised using
1% solution of lignocaine and in the event of pain occurring
during the procedure, additional anaesthetic was introduced
through the chamber of the biopsy needle. After the procedure
was completed, patients were asked to stay in the outpatient
clinic or hospital department for a short observation, with
the biopsy site compressed for 10–20min with an ice pack.
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Their biopsy sites having been controlled, patients were sent
home with an information sheet and further recommenda-
tions.
3. Results
All patients were qualiﬁed for removal of one breast lesion
at one procedure. The average procedure duration was
10–25min. A procedure was terminated upon removal of
the entire lesion, as visualised by the ultrasound image, or
when bleeding occurred preventing it from being continued.
The average size of excised lesions according to pre-biopsy
ultrasound image was 13.53±8.92mm (median 11mm, range
4–60mm). 108 (55.1%) lesions were located in left breasts, 88
(44.9%) in right ones. Tumours were most often found in the
outer upper quadrant – 107 cases (54.6%).
An average of 14.88±9.03 (median 13, range 2–60) tissue
casts were collected per biopsy. In 184 cases (93.9%) benign
lesions were found in the ﬁnal histopathologic examina-
tion. Of these, most commonly diagnosed was ﬁbroadenoma
(n=157, 80.1% of all lesions subjected to biopsy). Other benign
lesions identiﬁed included (in order of occurrence): adenosis
(sclerosing, simple, blunt duct, apocrine, tubular, microglan-
dular), UDH, microcalciﬁcations, cystic mastopathy, steatosis,
ﬁbrosis, inﬂammations, glandular enlargement, papillomato-
sis, lobular hyperplasia, radial scar, fat necrosis. Pre-cancer
lesions were found in 10 cases. Four patients were diagnosed
with atypical ductal hyperplasia (ADH), other four with ﬂat
epithelial atypia (FEA), one was diagnosed with both ADH and
FEA, and one with atypical lobular hyperplasia (ALH). Two
post-biopsy patients were diagnosed with invasive cancer. All
patients with diagnosed pre-cancer and cancer lesions were
qualiﬁed for extended surgical excision in hospital setting.
Non-radical removal of lesions was reported for six cases at
the time of biopsy. In two cases, vacuum-assisted core-needle
biopsy was not successful as lesions qualiﬁed for treatment
were too large (50 and 60mm) and located deep down the car-
diac muscle fascia. A similar parafascial location prevented
biopsy in one patient with a tumour of 5mm in diameter. In
two other patients residual lesions were left unremoved due
to heavy haemorrhage that disabled the procedure from being
completed. In one case, haemorrhage was so massive that a
surgical revision of the biopsy sitewasnecessary. Overall, after
follow-up ultrasound examinations performed in the surgery
clinic, four patients were qualiﬁed for subsequent surgical
resection of lesions that had been left behind.
Complications included pain, hematoma at the biopsy site,
and skin ecchymosis. None of the patients has reported infec-
tion of the biopsy site. All complications subsided within two
months following the procedure and had no serious clini-
cal consequences. All patients were happy with the cosmetic
effect of the procedure (Fig. 2).
4. DiscussionA tumour exhibiting clinical features of breast ﬁbroadenoma
is one of the most common causes of young women’s vis-
its to breast disease specialists. A palpable lesion in the
breast arouses patients’ anxiety about its oncologic poten-Fig. 2 – Core-needle biopsy procedure.
tial as well as cosmetic effect following removal of the lesion.
Having recognised the nature of the tumour, that is after
the triple conﬁrmation of the diagnosis by clinical exami-
nation, radiology and biopsy, a method of treatment may
be proposed to the patient. In the case of benign lesions, a
choice arises between surgical removal or close observation.
In most cases, singular lesions are removed surgically, mainly
because young patients’ are concerned about having a tumour
in their breast.4–8 Ultrasound-guided vacuum-assisted core-
needle biopsy is a new method that provides the beneﬁts of an
operative procedure, while eliminating some of its drawbacks.
For more than one decade, it has been recognised around the
world as a low-invasive technique of diagnosing and treating
benign breast lesions9. Importantly, this technique does not
require general anaesthesia. Another advantage it offers is the
size of a resulting scar. In the case of a surgery, it is usually
around 3–4 cm, while in the case of biopsy it is in the region
of 3–5mm (Fig. 3). It seems particularly essential for patients
concernedwith their appearance.10,11 Reliable histopathologic
material, collected to conﬁrm a benign nature of the lesion
and to exclude an invasive process, is an important prerequi-
site of a vacuum-assisted biopsy It should be mentioned that
vacuum-assisted biopsies are reported to cause fewer compli-
cations than a classical surgery. Of importance is also the cost
of the procedure, which in most countries is much lower than
that of a surgery and related hospitalisation. In Poland, costs
related to thework of an operating theatre are underestimated
and regarded as lower than the costs of purchase of a biopsy
needle.
The size of tumour is a limitation for an effective removal
by biopsy. As stated by Sperber et al., all lesions less
than or equal to 1.5 cm (mean volume 0.25mL) were com-
pletely excised. Of the lesions measuring 1.5–2.0 cm, 11 (55%)
were completely excised, while for diameters larger than
2 cm (mean volume 1mL) tumours could not be removed
completely.11 In Polish studies conducted by Stanek et al.
on a group of 28 patients, a complete ultrasound-conﬁrmed
removals of lesions were achieved in 82% of cases. In all of
them, histopathologic material was received.10 The study by
Grady et al. states that the incidence of ﬁbroadenoma reoccur-
rence following biopsy excision for lesions larger than 2 cm in
reports of practical oncology and rad
Fig. 3 – Two neighbouring scars in a single patient: one
following a classical surgical resection of ﬁbroadenoma
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loser to the aureola).
iameter is 15% after 22 months and as much as 33% after 5
ears of follow-up observation.11
75% of patients reported no pain, the remaining ones
eported but moderate pain during the procedure.11 Thur-
ey et al. note that 55% of patients report pain rated 3/10
ithin up to one week after the procedure.12 The post-biopsy
car was acceptable for all patients and after a year, hardly
oticeable in 40% of them. Frequently observed subcutaneous
xtravasation was found in 25% of patients, but not leading to
ny further consequences.11 Other signiﬁcant complications
ncluded livedo in 19% and infections in 6% of cases. 85% of
atients assessed the cosmetic effect as good.
Vacuum-assisted core-needle biopsy is an effective tool
nabling excision of breast ﬁbroadenomas.13,14 It combines
eatures of a lesion resection and histopathologic material
ollection providing an access with minimum invasiveness. It
arks another major step on the way towards minimal inva-
ive surgery, which may be comparable to open surgery versus
aparoscopy in gallstone treatment.iotherapy 1 6 ( 2 0 1 1 ) 32–35 35
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